NDAQ
48
3
WY
27
-7
SLG
71
-4
CSCO
53
2
SJM
29
-2
AEE
46
11
NFLX
69
5
AVB
72
3
DE
29
-3
CHK
5
-7
NWS
77
8
F
42
-4
SRE
30
-2
AEP
56
-2
PBI
30
7
ADT
55
25
AMGN
47
-13
CVX
23
-2
VMC
57
3
DNB
36
2
NDAQ
48
3
WY
27
-7
SLG
71
-4
CSCO
53
2
SJM
29
-2
AEE
46
11
NFLX
69
5
AVB
72
3
DE
29
-3
CHK
5
-7
NWS
77
8
F
42
-4
SRE
30
-2
AEP
56
-2
PBI
30
7
ADT
55
25
AMGN
47
-13
CVX
23
-2
VMC
57
3
DNB
36
2
Financhill
Back

Berry Global Group Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
48

BERY
Berry Global Group

Last Price:
60.85
Seasonality Move:
-0.53%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
48
Berry Global Group (BERY) is a Sell

Is Berry Global Group a Buy, Sell or Hold?

  • The current Berry Global Group [BERY] share price is $60.85. The Score for BERY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • BERY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BERY Stock Price Chart

What is Berry Global Group's stock price today?

  • The Berry Global Group share price today is $60.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BERY is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

BERY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.28 Buy
Relative Strength Index (14 RSI): 56.3 Buy
Chaikin Money Flow: 1234540 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (59.03 - 60.89) Buy
Bollinger Bands (100): (57.4 - 61.48) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

BERY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.92 Buy
20-day SMA: 59.83 Buy
50-day SMA: 59.01 Buy
200-day SMA: 60.99 Sell
8-day EMA: 60.27 Buy
20-day EMA: 59.97 Buy
50-day EMA: 59.68 Buy
200-day EMA: 60.53 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Berry Global Group Earnings Growth & BERY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.83 per share, an increase this year of $0.22 per share, and an increase next year of $0.72 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Berry Global Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):